Firms
Theme

ASST

Strive, Inc. Class A · NASDAQ

News

3 latest

GlobeNewswire Inc.

Strive Announces Pricing of Upsized Initial Public Offering of SATS Stock

Strive, Inc. (Nasdaq: ASST) priced its initial public offering of 7 million shares of 15.00% Series A Perpetual SATS Preferred Stock at $90 per share on October 15, 2026, raising approximately $630 million in gross proceeds. The company plans to use the net proceeds for bitcoin acquisitions, working capital, income-generating assets, and potential share repurchases. Settlement is scheduled for October 20, 2026.

Mentions ASST

The Motley Fool

Why Strive Stock Surged This Week

Strive stock surged 20.5% this week after completing a $630 million preferred stock offering to fund Bitcoin acquisitions. The company purchased 4,045 Bitcoins, bringing total treasury holdings to 36,818 coins worth approximately $3 billion. However, analysts caution that the stock trades at a 40% premium to its net asset value, making direct Bitcoin ETF investments a potentially better option for most investors.

Zacks Investment Research

Strategy Grows Bitcoin Holdings: Can Its Treasury Scale Drive More Value?

Strategy Inc. (MSTR) expanded its Bitcoin treasury by 26% to 848,000 BTC in 2026, funded through $17.06B in ATM programs and $7.53B in STRC issuances. However, the company reported negative 3.7% year-to-date BTC Yield and a $2.10B negative BTC dollar gain, indicating dilution risks outweigh treasury growth. MSTR trades at a steep 120.54 forward P/S ratio with an F Value Score, earning a Zacks Rank #3 (Hold) rating.

Headlines link to the publisher. Not investment advice.

Analysts

All ›

Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.

Community

7 days

No sentiment yet

Posts 24h
0
Replies 24h
0
Watchers
0

Board · $ASST · 0 threads

Sign in to post on $ASST

No threads yet

Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.

Cylvex is a financial simulation and community platform designed for educational and informational purposes only. Market data may be delayed. Nothing on this platform constitutes investment advice, financial advice, trading advice, or any other sort of advice. You should not treat any of the platform's content as such. Cylvex does not recommend that any financial instrument should be bought, sold, or held by you. Do conduct your own due diligence and consult your financial advisor before making any investment decisions. By using Cylvex, you acknowledge that you are using the platform at your own risk.

Terms · Privacy · Disclaimer · Methodology · Logos provided by Logo.dev